Avatar
Bakeryfile41

0 Following 1 Followers
1
Risk. Mild dengue fever presents with headache, fever, rash, myalgia, osteogenic pain, and lethargy. Severe disease can manifest as dengue shock syndrome (DSS) or dengue hemorrhagic fever (DHF). Symptoms of DSS/DHF are leukopenia, low blood volume and pressure encephalitis, cold and sweaty skin, gastrointestinal bleeding, and spontaneous bleeding from gums and nose. Currently, there are no therape
1
Risk. Mild dengue fever presents with headache, fever, rash, myalgia, osteogenic pain, and lethargy. Severe disease can manifest as dengue shock syndrome (DSS) or dengue hemorrhagic fever (DHF). Symptoms of DSS/DHF are leukopenia, low blood volume and pressure encephalitis, cold and sweaty skin, gastrointestinal bleeding, and spontaneous bleeding from gums and nose. Currently, there are no therape
1
Cence detection.Phase-contrast microscopy Phase-contrast microscopy was performed with a Zeiss Axiovert100 microscope and photomicrographs were taken with an AxioCam MRc5 digital camera.9.10.11.12.Competing interestsThe authors declare that they have no competing interests.13.Authors' contributionsSS participated in the experimental design, implementation and interpretation of results and performe
1
Ana (70112-2699) USA Email: David G Nielsen - dnielsen@tulane.eduPublished: 27 November 2009 Virology Journal 2009, 6:211 doi:10.1186/1743-422X-6-Received: 27 October 2009 Accepted: 27 NovemberThis article is available from: http://www.virologyj.com/content/6/1/211 ?2009 Nielsen; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribu
1
Ana (70112-2699) USA Email: David G Nielsen - dnielsen@tulane.eduPublished: 27 November 2009 Virology Journal 2009, 6:211 doi:10.1186/1743-422X-6-Received: 27 October 2009 Accepted: 27 NovemberThis article is available from: http://www.virologyj.com/content/6/1/211 ?2009 Nielsen; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribu
1
Ly Research Laboratories, Indianapolis, IN, USA) were made in dimethyl sulfoxide and diluted in medium, i.e., DMEM with 2.5 FBS, before use. Stock solutions of 10 mg/ml 2-AP; 4 mg/ml levamisole; 10 mg/ml L-NAME and 1 mg/ml L-NMMA were directly made in medium; hemin: a stock solution of 3.25 mg/ml was prepared by addingPage 8 of(page number not for citation purposes)Virology Journal 2008, 5:http:/
1
Risk. Mild dengue fever presents with headache, fever, rash, myalgia, osteogenic pain, and lethargy. Severe disease can manifest as dengue shock syndrome (DSS) or dengue hemorrhagic fever (DHF). Symptoms of DSS/DHF are leukopenia, low blood volume and pressure encephalitis, cold and sweaty skin, gastrointestinal bleeding, and spontaneous bleeding from gums and nose. Currently, there are no therape
1
Ana (70112-2699) USA Email: David G Nielsen - dnielsen@tulane.eduPublished: 27 November 2009 Virology Journal 2009, 6:211 doi:10.1186/1743-422X-6-Received: 27 October 2009 Accepted: 27 NovemberThis article is available from: http://www.virologyj.com/content/6/1/211 ?2009 Nielsen; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribu